Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 16Rituximab 14Magnetic Resonance Spectroscopy 8obinutuzumab 7fludarabine phosphate 7fludarabine 7Specimen Handling 7Prednisone 7Etoposide 6Biopsy 6tocilizumab 5polatuzumab vedotin 5ibrutinib 5X-Rays 5Whole-Body Irradiation 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Melphalan 5Lenalidomide 5Doxorubicin 5Mycophenolic Acid 4Cytarabine 4Cyclosporine 4Busulfan 4venetoclax 3pembrolizumab 3glofitamab 3acalabrutinib 3Vincristine 3Tacrolimus 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × carmustine, poliferprosan 20 drug combination × 30 days × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡